Back
BXN
Bioxyne Limited
🇦🇺 ASX
📈 HIGH PRICE GROWTH
🛍️ CONSUMER
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 33.85%
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
12
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Bioxyne Ltd. engages in the research, development, market and distribution of health products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-12-14. The firm is focused on health and wellness products, psychotropic and investigational medicines. The firm operates through three segments: Wholesale PCC/USA, Consumer Health Products UK/ EU/JPN, and Pharmaceuticals AUS. Its subsidiary, Breathe Life Sciences (BLS) manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabidiol (CBD), cannabis extracts, vitamins, manuka honey, skin care products and mushroom complexes. BLS operates in Australia, the United Kingdom, Japan, and Europe with four accredited manufacturing facilities across four countries Japan, Australia, the United Kingdom, and Czechia. The firm direct sales arm and has developed a range of functional food products containing ingredients sourced exclusively from New Zealand and sold in Asia.
📈 Performance
Price History
+257.14%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.04
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in BXN
12
📊 Total Capital Earnings
$3K
🔃 Average investment frequency
33 weeks
💵 Average investment amount
$1,362
⏰ Last time a customer invested in BXN
9 hours
BXN investor breakdown
💵 Income of investors
More than 200k
150k - 200k
12%
100k - 150k
50k - 100k
35%
Less than 50k
47%
👶 Age of investors
18 - 25
26 - 34
33%
35 - 90
67%
🙋 Legal gender of investors
Female
42%
Male
58%
Pearlers who invest in BXN also invest in...
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
21.53%
📊 Share price
$68.13 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
8.00%
📊 Share price
$110.45 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
⛳️ DIVERSIFIED
🧱 MATERIALS
Zip Co. Ltd. engages in the offering point-of-sale credit and payments to customers and providing integrated retail finance solutions to merchants, both online and in-store. The company is headquartered in Sydney, New South Wales. The company went IPO on 2009-12-09. The principal activity of the Company is offering point-of-sale credit and digital payment services to customers and providing integrated retail finance solutions to merchants, both online and in-store. The firm offers unsecured loans to consumers, both online and in-store, through the provision of line of credit and installment products. The firm provides services in four countries around the world, in Australia and New Zealand (ANZ), the United States and Canada (Americas). The Company’s segments include ANZ, Americas, Zip Business and Corporate. ANZ segment offers installment or line of credit products to consumers in Australia and New Zealand. Americas segment offers installment products to customers in the United States and Canada. Zip Business segment provides unsecured loans and lines of credit to small and medium-sized businesses in Australia and New Zealand.
🙌 Performance (5Yr p.a)
-7.73%
📊 Share price
$4.65 AUD
💸 FINANCIALS
Telix Pharmaceuticals Limited.engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-15. The company is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
🙌 Performance (5Yr p.a)
142.26%
📊 Share price
$14.36 AUD
🕊️ SOCIALLY AWARE
🧬 BIOTECHNOLOGY
ATEC.AX was created on 2020-03-04 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The investment objective of the Fund is to provide an investment return that aims to track the performance of the S&P/ASX All Technology Index (the Index), before taking into account fees and expenses.
🙌 Performance (5Yr p.a)
9.69%
📊 Share price
$31.74 AUD
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
📞 COMMUNICATIONS
Want more shares? Try these...
